Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.68 USD | +2.29% | +3.08% | +77.48% |
17/04 | RBC Raises Price Target on Nuvation Bio to $5 From $4, Keeps Outperform, Speculative Risk | MT |
10/04 | Nuvation Bio Closes Acquisition of AnHeart Therapeutics | MT |
Business Summary
Number of employees: 51
Managers
Managers | Title | Age | Since |
---|---|---|---|
David Hung
FOU | Founder | 66 | 20/18/20 |
Moses Makunje
DFI | Director of Finance/CFO | 46 | 01/20/01 |
Dong Fang Liu
CTO | Chief Tech/Sci/R&D Officer | 54 | 18/22/18 |
Gary Hattersley
CTO | Chief Tech/Sci/R&D Officer | 57 | 01/19/01 |
David Hanley
PRN | Corporate Officer/Principal | 54 | 01/21/01 |
Stacy Markel
HRO | Human Resources Officer | 59 | 01/19/01 |
Kerry Wentworth
LAW | General Counsel | 51 | 18/22/18 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
David Hung
FOU | Founder | 66 | 20/18/20 |
Kim Blickenstaff
BRD | Director/Board Member | 71 | 01/19/01 |
Kathryn Falberg
BRD | Director/Board Member | 63 | 01/20/01 |
Daniel Welch
CHM | Chairman | 66 | 01/20/01 |
Robert D. Mashal
BRD | Director/Board Member | - | 08/01 |
Tony Vernon
BRD | Director/Board Member | 68 | 01/19/01 |
Director/Board Member | 56 | 01/20/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,000,000 | 0 | 0 | 75.17 % |
Stock B | 1 | 245,692,474 | 185,427,238 ( 75.47 %) | 0 | |
Stock C | 0 | 851,202 | 0 | 0 |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+77.48% | 704M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- NUVB Stock
- Company Nuvation Bio Inc.